Independent predictive value of blood inflammatory composite markers in ovarian cancer: recent clinical evidence and perspective focusing on NLR and PLR
C Zhang, X Jiang, Y Li, X Pan, M Gao, Y Chen… - Journal of ovarian …, 2023 - Springer
Ovarian cancer (OC) is one of the deadliest malignant tumors affecting women worldwide.
The predictive value of some blood inflammatory composite markers in OC has been …
The predictive value of some blood inflammatory composite markers in OC has been …
Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer
W Wang, Y Tong, S Sun, Y Tan, Z Shan, F Sun… - Frontiers in …, 2022 - frontiersin.org
Purpose Pretreatment neutrophil-to-lymphocyte (NLR) and platelet-to-lymphocyte (PLR)
ratios are markers of systemic inflammation. In patients with locally advanced gastric cancer …
ratios are markers of systemic inflammation. In patients with locally advanced gastric cancer …
Neutrophils in cancer drug resistance: Roles and therapeutic opportunities
H Liu, H Zhao, M Zhou, X Zhao, Y Lu - Cancer Letters, 2024 - Elsevier
The tumor microenvironment (TME) is closely associated with the therapeutic response and
clinical outcome of cancer drug therapies, which mainly include immunotherapy …
clinical outcome of cancer drug therapies, which mainly include immunotherapy …
High-grade serous ovarian cancer development and anti-PD-1 resistance is driven by IRE1α activity in neutrophils
A Emmanuelli, C Salvagno, SM Hwang… - …, 2024 - Taylor & Francis
High-grade serious ovarian cancer (HGSOC) is an aggressive malignancy that remains
refractory to current immunotherapies. While advanced stage disease has been extensively …
refractory to current immunotherapies. While advanced stage disease has been extensively …
Prognostic role of neutrophil, monocyte and platelet to lymphocyte ratios in advanced ovarian cancer according to the time of debulking surgery
A Plaja, I Teruel, M Ochoa-de-Olza, M Cucurull… - International Journal of …, 2023 - mdpi.com
Despite a multimodal radical treatment, mortality of advanced epithelial ovarian cancer
(AEOC) remains high. Host-related factors, such as systemic inflammatory response and its …
(AEOC) remains high. Host-related factors, such as systemic inflammatory response and its …
[HTML][HTML] Predictive value of the systemic immune-inflammation index for the efficacy of neoadjuvant chemotherapy and prognosis in patients with stage III ovarian …
J Wang, S Yin, K Chen - Gland Surgery, 2022 - ncbi.nlm.nih.gov
Background The systemic immune-inflammation index (SII) has been proven to be related to
the prognoses of multiple malignant tumors. However, there are still few studies on the …
the prognoses of multiple malignant tumors. However, there are still few studies on the …
Immune profile of blood, tissue and peritoneal fluid: a comparative study in high grade serous epithelial ovarian cancer patients at interval debulking surgery
High-grade serous epithelial ovarian carcinoma (HGSOC) is an immunogenic tumor with a
unique tumor microenvironment (TME) that extends to the peritoneal cavity. The …
unique tumor microenvironment (TME) that extends to the peritoneal cavity. The …
Potential tools for predicting response to chemotherapy in OC: Assessment of immune dysbiosis, participant's self-rated health and microbial dynamics
T Badger, E Anderson, S Nelson, K Groesch… - Journal of Reproductive …, 2024 - Elsevier
Epithelial ovarian cancer (OC) is the deadliest female reproductive cancer; an estimated
13,270 women will die from OC in 2023. Platinum-based chemotherapy resistance …
13,270 women will die from OC in 2023. Platinum-based chemotherapy resistance …
Prognostic value of systemic inflammation response indexes obtained from the complete blood count in patients treated for advanced ovarian carcinoma in front line
J Espinós, JM Aramendía, A González-Martín… - Clinical and …, 2024 - Springer
Objective Various systemic inflammation response indexes (SIRI) have repeatedly been
described as prognostic factors in ovarian cancer. They have not been validated in …
described as prognostic factors in ovarian cancer. They have not been validated in …
The evaluation value of CT in the efficacy of Neoadjuvant Chemotherapy in Ovarian Cancer Patients
D Mou, S Xie, P Li - Contrast Media & Molecular Imaging, 2022 - Wiley Online Library
Aim. To discuss the evaluation value of CT in the efficacy of neoadjuvant chemotherapy in
patients with ovarian cancer. Methods. The clinical, pathological, and CT imaging …
patients with ovarian cancer. Methods. The clinical, pathological, and CT imaging …